Chunzhen Zhao†
ad,
Changxiao Du†cd,
Jie Xu†a,
Yuqing Zhao†d,
Xiaoming Shie,
Dong Zhange,
Xinmiao Zhangd,
Yi Zhangd,
Han Sund,
Xixin Jiangd,
Zhen Dud,
Mengjin Wangd,
Meimei Xiao*c and
Mingwen Zang*bc
aAffiliated Hospital of Shandong Second Medical University, Shandong Second Medical University, 261053 Shandong, PR China
bWeifang Brain Hospital, Weifang, Shandong, PR China
cWeifang People's Hospital, Shandong Second Medical University, Weifang, Shandong, PR China. E-mail: 511017186@qq.com; 806002570@qq.com
dSchool of Pharmacy, Shandong Second Medical University, Weifang, 261053 Shandong, PR China
eShandong Neptunus Galaxy Pharmaceutical Co., Ltd, Weifang, Shandong, PR China
First published on 1st September 2025
The escalating challenges associated with antibiotic resistance have posed formidable obstacles in the fight against microbial infections and the prevention of biofilm formation. To address this challenge, we developed PEB-COP-Cu, a low-cost, readily available copper-integrated covalent organic polymer (COP) with dual enzyme-like activities and intrinsic photoresponsiveness, to accelerate infected wound healing. This material was synthesized through the post-metallization process of a COF xerogel (PEB-COP), obtained via a Michael addition elimination reaction, utilizing photoactive tetra-(4-aminophenyl)porphyrin (TAPP) and β-ketoenamine, specifically 1,3,5-tris(3-dimethylamino-1-oxoprop-2-en-yl)benzene (abbreviated as TDOEB), as the fundamental building blocks. PEB-COP-Cu enables multimodal antimicrobial action through integrated photothermal therapy (PTT) and type I/II photodynamic therapy (PDT), generating reactive oxygen species (ROS) in both oxygenated and hypoxic environments. This material demonstrates dual mimicking enzymatic activities (oxidase and peroxidase) to achieve ROS-mediated bacterial inactivation with or without H2O2. Specifically, under H2O2-deficient conditions, it catalyzes oxygen conversion to produce superoxide anions (O2˙−), while in H2O2-excess scenarios, it also depletes excessive H2O2 to enhance ˙OH generation. The synergistic integration of these enzymatic cascades with PTT/PDT establishes a comprehensive antimicrobial system that operates through coordinated molecular mechanisms. This combined therapeutic strategy demonstrates threefold therapeutic advantages, which could effectively eradicate bacteria, inhibit biofilm formation, and promote wound healing via harnessing and modulating the infectious microenvironment (IME). Our findings establish PEB-COP-Cu as a pioneering therapeutic platform that simultaneously addresses the key challenges of conventional enzymatic therapy, achieving significantly improved biocidal efficacy while minimizing off-target cytotoxicity.
Photothermal therapy (PTT) and photodynamic therapy (PDT) are two primary noninvasive techniques harnessing the synergy of photosensitizers (PSs) and light sources to combat antimicrobial resistance.6 PTT leverages the local hyperthermia to eliminate bacteria via the photothermal conversion realized by PSs upon absorbing specific light wavelengths.7 To effectively eliminate bacteria, high temperatures are frequently necessary, along with substantial doses of medication.8 However, this approach not only causes irreparable harm to normal cells, but also presents a significant challenge in achieving a balance between bacterial eradication and the preservation of healthy tissue.9 PDT disrupts the cellular structure of pathogens by generating reactive oxygen species (ROS) catalyzed by the PSs under laser illumination.10 However, the efficacy of PDT is significantly hampered by the concentration of oxygen, particularly in skin lesions where blood vessels are severely compromised, resulting in a treatment outcome falling short of expectations.11
Enzyme therapies are flourishing catalytic based antimicrobial model, which features the characteristics of high efficiency, specificity and low resistance.12 However, the traditional enzyme therapy is concurrently challenged by the high preparation cost, as well as the intrinsic instability in both the structure and activity of natural enzymes under different media.13 Artificial enzymes with the mimicking activity to the natural enzyme have emerged as alternatives for the enzyme therapy, which greatly boosting the development of enzyme therapy.14 Peroxidase-like (POD-like) enzymes generally catalyze the decomposition of peroxides hydrogen (H2O2) to generate the toxic hydroxyl radicals (˙OH) to kill bacteria.15,16 Whereas, the real application of POD-like enzyme in the antimicrobial field is severely blocked by the limited activity in the IME, such as the low concentration of H2O2.17
Combination therapy realized by integrating different technologies, have stand out from the crowd to strength the efficacy of enzyme therapy at a low dose, but yield superior outcomes in antimicrobial therapy. For example, the combination of PTT with enzyme therapy.18 Specifically, as a catalysis-based therapy, the reaction rate is significantly influenced by the reaction temperature. And the selective increase of the temperature at the lesion location has emerged as a focal point of current research to increase the enzyme activity.19 However, the functional integration requires the design of appropriate materials via reasonable structure design. Therefore, it remains the difficulty of current research to seamlessly integrate diverse therapies into a platform maximizing the therapeutic effect.20
Covalent organic polymers (COPs), especially these with fully conjugated skeleton structure, exhibit distinctive features, such as exceptional chemical stability, and favorable biocompatibility, rendering them exceptionally suitable as PSs.21 Meanwhile, the customizable structures and functions empower multiple functionality with COPs as ideal platform for the multimodal synergy therapy, optimizing therapeutic efficacy, while minimizing collateral damage to surrounding healthy tissues.22 Nonetheless, the synthesis of COPs typically involves stringent conditions, necessitating meticulous control over reaction temperature and pressure, as well as the use of environmentally harmful corrosive solvents.23 Currently, the targeted crafting of COPs with desirable functions under environmentally friendly and gentle conditions poses a significant challenge in contemporary research, especially those with customized multiple enzyme activities.
This study employs a green and low cost Michael addition–elimination reaction to synthesize the photoactive COP hydrogel using tetra-(4-aminophenyl)porphyrin (TAPP) and β-ketoenamine (1,3,5-tris(3-dimethylamino-1-oxoprop-2-en-yl) benzene, TDOEB) as building blocks. The reaction proceeds under ambient conditions in aqueous medium.24 Lyophilization of the hydrogel yields PEB-COP with a fully conjugated skeleton, exhibiting superior photoactivity compared to TAPP. The coexistence of porphyrin chromophores and alkenylamine linkages in PEB-COP endows it with dual Cu2+ coordination sites, enabling POD-like and OXD-like functionalities upon Cu2+ chelation. This integration not only activates ROS generation for enhanced enzymatic therapy but also extends the conjugated system through Cu2+-induced skeleton extension. Such structural modification broadens the light absorption spectrum, strengthens photothermal conversion efficiency, and consequently amplifies both PDT and PTT outputs. The synergistic effect of these photo-activated therapies establishes Por-EB-COP-Cu as a four-in-one antimicrobial platform. This work presents a green, facile synthetic strategy for developing multifunctional sterilizing agents, offering innovative solutions to improve infected wound management through IME modulation.
![]() | ||
Scheme 1 Schematic route for the synthesis of PEB-COP-Cu and corresponding mechanism of wound healing promotion. |
The backbone structure of the PEB-COP and PEB-COP-Cu was concurrently characterized using Fourier Transform Infrared Spectroscopy (FT-IR) and solid-state 13C Cross-Polarized Magic Angle Rotational Nuclear Magnetic Resonance (Solid-State 13C NMR). The FT-IR spectrum (Fig. 1a) exhibited the disappearance of the stretching vibration of primary amine (3371 cm−1) and N–CH3 (1438 cm−1) indexed to TAPP TDOEB, respectively, confirming the occurrence of the Michael addition–elimination reaction.26,27 The emergence of the characteristic signal of secondary amine (Ar–NH) at approximately 1120 cm−1 verified the formation of alkenylamine linkages over the porous skeleton.28 Meanwhile, the signals near 715 and 955 cm−1 corresponding to the Cu–O and Cu–N bonds confirmed the successful incorporation of Cu into the COP skeleton.29,30 As shown in Fig. 1b, the solid-state 13C NMR spectrum of PEB-COP-Cu exhibited five distinct characteristic signals at 189, 138, 131, and 120 ppm, respectively. The characteristic peak observed at 138 ppm corresponded to the porphyrin-bridged carbon (c) (C–NH) and the α-carbon (a) of the carbonyl group in TDOEB.31 The signals at 131 ppm and 120 ppm were identified as conjugated olefins in the porphyrin structure, whereas the residual resonance at 188 ppm was ascribed to the carbonyl carbon in the vinyl ketone portion of the (CO).32
The X-ray photoelectron spectroscopy (XPS) was collected to explore the surface elemental composition of PEB-COP-Cu. The survey spectrum revealed the co-existence of characteristic peaks of C (53.73 at%), N (5.63 at%), O (30.44 at%) and Cu (10.21 at%) located at 284.8, 397.9, 531.6 and 934.7 eV, respectively (Fig. 1c). The high-resolution C 1s spectra was separated into 4 peaks with binding energy (BE) of 284.8, 286.2, 287.7 and 289.8 eV (Fig. 1d), They are attributed to CC,C
N,C
O and πhe* bonds, respectively.33 The N 1s spectrum was were fitted into 3 peaks with binding emerging of 397.9, 398.6 and 399.6 eV, belonging to the C–NH, C
N and N–Cu (Fig. 1e), respectively.34 The O 1s spectrum of PEB-COP-Cu in Fig. 1f shows two peaks, one centred at 531.6 eV representing the C–O–Cu bond and the other centered at 532.9 eV representing the C
O bond.35 Furthermore, the high resolution spectra of Cu 2p from PEB-COP-Cu indicate the coexistence of Cu(I) and Cu(II) substances on the sample surface. The Cu 2p3/2 XPS spectra were fitted and merged into two peaks at 935.1 and 933.7 eV, associated with Cu(II) and Cu(I), respectively. Similarly, the fitting of the Cu 2p1/2 XPS spectrum resulted in two peaks at 952.2 and 954.6 eV, associated with Cu(I) and Cu(II) substances, respectively (Fig. 1g).33,36 These results unequivocally validated the successful preparation of PEB-COP-Cu. The thermogravimetric analysis (TGA) of PEB-COP-Cu (Fig. 1h) revealed PEB-COP-Cu were stable up to 200 °C with a tiny weight loss less than 5.0% below 100 °C attributed to the evaporation of water strongly absorbed in the heteroatom-rich porous skeleton. And a gradual mass loss was detected with the continuous increase of temperature. Remarkably, the material demonstrated exceptional thermal stability, retaining more than 58% of its initial mass even at elevated temperatures up to 800 °C.
The powder X-ray diffraction (XRD) patterns of the PEB-COP-Cu displayed obvious diffraction peaks at 12.5°, 25.7°, and 33.4°, corresponding to the (100), (110), and (220) crystal planes of the layer stacked skeleton (Fig. 1i).37,38 Low temperature N2 adsorption–desorption measurement was performed to investigate the inherent porosity of PEB-COP-Cu sample at 77 K. As shown in Fig. S1, PEB–COF–Cu exhibited a hierarchical pore structure dominated by both micropores and mesopores, as evidenced by its type II isotherm. The nearly vertical uptake observed at low pressure range (P/P0 < 0.0155) clearly indicated the presence of micropores. Furthermore, the pronounced hysteresis loop appearing in the adsorption–desorption curves within the relative pressure range of 0.19 < P/P0 < 0.96 confirms the existence of mesopores.39 The specific surface area (SBET) of PEB-COP-Cu utilizing the Brunauer–Emmett–Teller (BET) method was determined to be 28.1 m2 g−1 with a cumulative pore volume of 0.048 cm3 g−1. Meanwhile, the pore size distribution (PSD) curve (Fig. S2) provided further evidence on the hierarchical pore structure with a main peak centered at 1.2 nm accompanying two secondary peaks located at 2.5 and 5.8 nm, respectively.
The hierarchical structure of PEB–COF–Cu was systematically characterized using scanning electron microscopy (SEM, Fig. 2a and b) and transmission electron microscopy (TEM, Fig. 2c–f). SEM images revealed a blocky aggregation morphology with a distinct layered lamellar assembly (Fig. 2a), while TEM observations demonstrated an interconnected porous network within the polymer skeleton (Fig. 2c). High-resolution TEM (HR-TEM, Fig. 2g and h) further revealed abundant micropores distributed throughout the framework, distinguishable by light/dark contrast (Fig. 2g). Notably, the inset HR-TEM image (Fig. 2h) showed ordered lattice stripes with a clear spacing of 0.249 nm, corresponding to the (100) plane of the layered structure.40 Elemental mapping (Fig. 2i) and energy-dispersive X-ray spectroscopy (EDS, Fig. S3) confirmed homogeneous elemental distribution across the C-based matrix. Quantitative analysis yielded C (7.8%), N (0.25%), O (24.3%), and Cu (67.5%) contents, with Cu atoms preferentially localized in the porous regions.41
The fully conjugated structure and the specific compositions inspired us to investigate the optical physical performance of PEB-COP-Cu. Initially, the UV-Vis spectroscopic measurements were conducted to explore the optical absorption properties of PEB-COP-Cu (Fig. S4).42 As seen, PEB-COP-Cu exhibited a broad-spectrum light absorption capability spanning from 200 to 800 nm with an extinction coefficient at 638 nm of 1.95 × 10−3 mL μg−1 cm−1. Subsequently, the photothermal conversion capacity of PEB-COP-Cu was comprehensively evaluated by systematically monitoring the temporal temperature variations of the media via controlled altering either the material concentration or laser power density.43 As illustrated in Fig. 3a, PEB-COP-Cu exhibited concentration-dependent photothermal heating performance under 638 nm laser irradiation (1.5 W cm−2). The temperature elevation (ΔT) of aqueous dispersions increased progressively from 7.7 to 28.0 °C with concentration escalation from 50 to 250 μg mL−1 during 10 min irradiation, while the control aqueous solution maintained negligible temperature fluctuations. Fig. 3b demonstrated a positive correlated relationship between laser power density (0.5–1.5 W cm−2) and temperature rise. For a PEB-COP-Cu suspension (250 μg mL−1), the temperature increased from 26.5 °C to 35.3, 38.5, 43.1, 46.2, and 53.7 °C, as the laser power increase from 0.5 to 0.75, 1.0, 1.25 and 1.5 W cm−2, respectively. The dose-dependent photothermal behavior of PEB-COP-Cu was investigated using infrared thermography (Fig. 3c). As expected, higher concentrations of PEB-COP-Cu exhibited proportional temperature elevation, with maximal heating observed at 250 μg mL−1.
The dose- and laser power-dependent photothermal response of the PEB-COP-Cu could also be intuitively observed from the plots of peak temperature rise with the variation of concentrations and laser powers, from which nearly linear relationship were evident (Fig. 3d). To elucidate the role of Cu2+ coordination, we compared the photothermal performance of PEB-COP-Cu with PEB-COP and TAPP under identical conditions (250 μg mL−1, 638 nm, 1.5 W cm−2, 10 min). As shown in Fig. 3e, a notable disparity was observed in the photothermal performance of the PEB-COP-Cu compared with the pristine COP and pure TAPP, where the PEB-COP-Cu demonstrated a much superior warming capability (53.7 °C vs. 47.3 °C for PEB-COP and 43.4 °C for TAPP). This superior performance originated from the synergistic interplay between the highly planar π-conjugated architecture and the bimetallic active sites, which collectively facilitated extensive electron delocalization within the framework, underscoring the strategic importance of metal-ion doping in optimizing photothermal therapy outcomes. The photothermal stability of PEB-COP-Cu was systematically evaluated through five cyclic laser irradiation experiments (Fig. 3f). As seen, PEB-COP-Cu exhibited exceptional thermal robustness, with negligible temperature fluctuations across all cycles, confirming its long-term operational reliability. The photothermal conversion efficiency (η) was quantified using eqn (S1)–(S3) based on a single heating–cooling cycle protocol.44 As shown in Fig. 3g, the η value reached 42.6% (R2 = 0.994, τs = 250 s), surpassing many conventional POP-based photothermal agents (Table S1). To assess long-term aqueous stability, PEB-COP-Cu was stored in water for 14 days before photothermal testing (Fig. 3h). As seen, the temperature profiles remained identical to the initial measurements, demonstrating complete retention of photothermal activity and structural integrity. Meanwhile, PEB-COP-Cu dispersed in PBS at pH 7.4 demonstrated exceptional stability across dual testing protocols. UV-Vis spectra maintained precise overlap during 10 min exposure to 638 nm laser irradiation with measurements taken at 2 min intervals, confirming outstanding photostability (Fig. S7a). Concurrently, accelerated aging tests at 37 °C only showed slight absorbance variation after 30 days with measurements every 10 days, verifying long-term physiological stability (Fig. S7b). These results together validate its robustness for biomedical applications. Such superior stability demonstrated the great application potential of PEB-COP-Cu as a reusable and durable photothermal agent for antimicrobial therapy, where consistent heat generation was critical for bacterial eradication and wound healing.
Then, the mimicking enzyme activities of PEB-COP-Cu was evaluated. Initially, the oxidase-like (OXD) activity of PEB-COP-Cu was investigated via the chemical chromogenic method utilizing 3,3′,5,5′-tetramethylbenzidine (TMB) as a chromogenic substrate.45 As illustrated in Fig. 4a, only in the media containing PEB-COP-Cu and TMB, simultaneously, obvious color change accompanied by distinctive UV absorption of oxTMB (652 nm), could be clearly observed. The PEB-COP-Cu displayed a pH-dependent enzyme activity progressively intensified with increasing acidity (Fig. 4b). Notably, PEB-COP-Cu also displayed a significant enzyme activity even at the acidity akin to the infectious microenvironment (pH = 5.5). Furthermore, the role of oxidizing agent (O2) on the reaction system was also studied. As shown in Fig. 4c, the enzyme activity demonstrated a pronounced enhancement under oxygen-saturated conditions compared to argon (Ar)- or air-saturated media. However, the mimicking-OXD activity underwent a significant decline in an argon-filled environment. This observation suggested PEB-COP-Cu catalyzed the oxidation of TMB through the utilization of O2 to produce reactive oxygen species (ROS).46 To probe the ROS generated during the oxidation of TMB, we used 5 mM isopropanol (IPA), D-histidine (L-HD), p-benzoquinone (BQ), and ethylenediaminetetraacetic acid (EDTA), as trapping agents for the hydroxyl radicals (˙OH), singlet-linear oxygen (1O2), superoxide anion (O2˙−) and hole (h+), respectively. As illustrated in Fig. 4d, compared with the minor decrease upon the addition of IPA and L-HD, the absorbance of the system exhibited a much substantial decline with the incorporation of BQ and EDTA. This consequence indicated the ROS produced by PEB-COP-Cu during the mimicking-OXD process were primarily O2˙− and h+, while ˙OH and 1O2 were generated in significantly smaller amounts. Based on these experimental results, it could be inferred that within the reaction system consisting of PEB-COP-Cu and TMB, dissolved oxygen (O2) captured electrons transferred from PEB-COP-Cu, leading to its reduction to O2˙− and the simultaneous formation of h+. These species, in combination, significantly enhanced the catalytic efficiency of the direct oxidation of TMB, resulting in the formation of the color-developing product (oxTMB).47 Thereby, even in the environment without H2O2, the as-prepared PEB-COP-Cu could also exert the antibacterial ability.
Meanwhile, the peroxidase-like (POD-like) activity of PEB-COP-Cu was also evaluated using TMB as a standard chromogenic substrate.48 As presented in Fig. 4e, the characteristic absorbance at 652 nm for the PEB-COP-Cu + TMB + H2O2 system was higher than the PEB-COP-Cu + TMB system. This result revealed PEB-COP-Cu not only displayed oxidase-like (OXD-like) activity but primarily possesses significant POD-like activity, which could swiftly catalyze the decomposition of H2O2 to generate the highly oxidizing ˙OH, exhibiting POD-like activity. As illustrated in Fig. 4f, the mimicking activity of PEB-COP-Cu was also concerned with the media pH. Specifically, the POD-like activity first increased and then decreased with increasing acidity, which reached the maximal activity at the pH of 3.5. Notably, PEB-COP-Cu showed strong enzyme activity under acidity conditions comparable to the IME (pH 5.5). Furthermore, the oxidizing capability was proportional to the concentration of PEB-COP-Cu, which was progressively increased with rising concentration (Fig. 4g). Similarly, different ROS scavengers (IPA, L-HD, BQ and EDTA) were used to evaluate the POD-like catalytic mechanism of PEB-COP-Cu. The results in Fig. 4h showed the addition of IPA significantly reduced the absorbance of the PEB-COP-Cu + TMB + H2O2 group compared to the PEB-COP + TMB group, confirming the production of large amounts of ˙OH.46 And the POD-like activity was further enhanced under laser illumination (Fig. 4i).49 To elucidate the temperature-dependent enzymatic behavior, we systematically evaluated the POD-like and OXD-like activities of PEB-COP-Cu across a physiological to hyperthermal range (37–65 °C). Results demonstrated both the POD and OXD activities peaked at 45 °C, with enzymatic performance declining significantly above 55 °C (Fig. S8).
As illustrated in Fig. 5a, upon laser irradiation (638 nm, 1.0 W cm−2), photosensitive materials could dissipate energy through three primary pathways, including the fluorescence emission, vibrational relaxation (heat generation), and intersystem crossing (ISC), which generates triplet states and enhances reactive oxygen species (ROS) production.50 To evaluate the PDT capacity of PEB-COP-Cu, we quantified ROS generation using 1,3-diphenylisobenzofuran (DPBF) as a singlet oxygen (1O2) probe and dihydrorhodamine (DHR) as a superoxide anion (O2˙−) indicator. As shown in Fig. 5b, the absorption of DPBF at 415 nm (characteristic of 1O2 quenching) remained stable in the absence of PEB-COP-Cu. However, upon introducing PEB-COP-Cu and laser irradiation (Fig. 5c and d), the DPBF signal decreased by 99.62 ± 0.14% within 5 min, which was 8-fold higher than the control group (11.73 ± 0.62%, Fig. 5e). This result confirmed that PEB-COP-Cu efficiently converted molecular oxygen into 1O2 via a Type II PDT mechanism.51 As displayed in Fig. 5f and g, the Type II photodynamic activities of PEB-COP-Cu was positively correlated with both the sample concentration and the laser powers. Furthermore, as shown in Fig. 5h, a notable increase in fluorescence absorption by DHR was detected when exposed to laser. Additionally, as displayed in Fig. 5i, electron paramagnetic resonance (EPR) further confirmed the generation of O2˙− under laser illumination.52 This dual ROS-generating capability enabled PEB-COP-Cu to perform mixed Type I/II PDT, overcoming the limitations of hypoxia-associated treatment inefficiency. The integrated ROS-mediated pathways provided a synergistic antimicrobial strategy, effectively eradicating bacteria through oxidative stress while promoting wound healing.
Based on the exceptional photothermal, photodynamic and dual enzymatic activities, the in vitro antimicrobial activity of PEB-COP-Cu was assessed through the plate counting method, employing Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli), as the representative strains of Gram-positive (G+) and Gram-negative (G−) bacteria (Fig. 6).53 As seen from Fig. 6a and c, in stark contrast to the control group, the PEB-COP-Cu alone also presented obvious sterilizing activity ascribed to the intrinsic OXD-activity. Notably, upon the exertion of laser irradiation (638 nm, 1.0 W cm−2, 10 min) and H2O2 (10 mmol L−1), and the bactericidal ability of PEB-COP-Cu was prominently enhanced which also exhibited a concentration-dependent manner. Their bactericidal potential against both S. aureus (Fig. 6a) and E. coli (Fig. 6c) was significantly enhanced with increasing concentration. At a concentration of 50 μg mL−1, only moderate bactericidal effect was observed in the PEB-COP-Cu group, with inhibition rates of 23.70 ± 1.56% and 17.65 ± 2.97% against S. aureus (Fig. 6b) and E. coli (Fig. 6d), respectively, assigned to the OXD-like enzyme activity. However, upon the addition of H2O2, the inhibitory effect of the PEB-COP-Cu + H2O2 group was increased to 27.75 ± 1.09% and 24.16 ± 4.53% against S. aureus (Fig. 6b) and E. coli (Fig. 6d), respectively, due to the catalysis of the OXD-like and POD-like enzymes. In contrast, the PEB-COP-Cu + H2O2 + laser group showed high inhibition towards both bacteria (36.46 ± 1.97% for S. aureus and 63.40 ± 2.92% for E. coli) attributed to the multiple therapies. With the concentration of 400 μg mL−1, PEB-COP-Cu alone achieved significant inhibition against both pathogens with 82.75 ± 1.99% and 70.66 ± 1.18% for E. coli and S. aureus, respectively. The PEB-COP-Cu + H2O2 combination markedly enhanced efficacy, exceeding 90% inhibition for both stains (96.30 ± 0.49% and 93.69 ± 0.34% for E. coli and S. aureus). Near-total eradication was observed with PEB-COP-Cu + H2O2 + laser treatment at the sample concentration of 300 μg mL−1 (99.17 ± 0.21%, and 97.31 ± 0.01% for E. coli and S. aureus). To assess the therapeutic efficacy of PTT, S. aureus and E. coli were separately co-cultured with PEB-COP-Cu across a concentration gradient (0–300 μg mL−1). To isolate photothermal effects from photodynamic contributions, ROS scavengers were introduced during bacterial co-culture. Following exposure to laser irradiation, bactericidal efficacy was quantified via plate counting. Results demonstrated dose-dependent thermal killing, with bacterial viability at the maximum concentration (300 μg mL−1) reduced to 24.50 ± 1.06% for S. aureus and 26.30 ± 1.17% for E. coli.
Furthermore, recognizing the urgent need for new antimicrobials against difficult-to-treat pathogens, we selected Pseudomonas aeruginosa (P. aeruginosa), a clinically critical multidrug-resistant bacterium, as a model to rigorously assess the antimicrobial efficacy of PEB-COP-Cu against challenging targets. After co-culture across a concentration gradient (0–300 μg mL−1), PEB-COP-Cu treatment exhibited a robust, dose-dependent bactericidal effect. Critically, this culminated in near-complete bacterial eradication, with survival plummeting to a mere 12.24 ± 0.42% at the highest concentration tested (300 μg mL−1, Fig. S10). This potent efficacy unequivocally demonstrated not only the intrinsic bactericidal capacity of PEB-COP-Cu, but also strongly suggested its ability to effectively bypass the common resistance mechanisms of this problematic pathogen. Consequently, PEB-COP-Cu represented a highly promising candidate for combating drug-resistant bacterial strains.
To elucidate the sterilization mechanism and optimize therapeutic strategies, S. aureus and E. coli were subjected to eight distinct treatments (250 μg mL−1), including the PBS control, PBS + laser, PEB-COP, PEB-COP + laser, PEB-COP-Cu, PEB-COP-Cu + laser, PEB-COP-Cu + H2O2, and PEB-COP-Cu + H2O2 + laser. Fig. 7 demonstrated bacterial viability after 12 h incubation across these experimental groups. As depicted in Fig. 7a and c, the bacterial colonies in the PBS groups exhibited comparable numbers regardless of the laser irradiation. However, the antimicrobial efficacy of PEB-COP, PEB-COP-Cu, and PEB-COP-Cu + H2O2 was notably enhanced after the laser irradiation, especially the PEB-COP-Cu + H2O2. Specifically, the PEB-COP + laser group demonstrated 63.31 ± 2.23% and 59.71 ± 2.59% antimicrobial activity against S. aureus and E. coli, respectively, much high than that in the laser free conditions (9.72 ± 2.34% and 10.71 ± 0.91%). In contrast, the PEB-COP-Cu + laser group showed 85.73 ± 0.61% and 91.2 ± 0.77% inhibition against S. aureus and E. coli, respectively, much higher than these in the laser free conditions (15.42 ± 1.65% and 45.62 ± 1.09%). Notably, the inhibition of S. aureus and E. coli in the PEB-COP-Cu + H2O2 group soared to 95.80 ± 0.31% and 96.78 ± 0.26%, respectively, after laser radiation (Fig. 7b and d). Among all treatments, the PEB-COP-Cu + H2O2 group demonstrated the most pronounced antimicrobial effect, attributed to the synergistic photodynamic-photothermal and dual enzyme antimicrobial properties of PEB-COP-Cu.
TEM revealed distinct morphological alterations in S. aureus and E. coli following PEB-COP-Cu treatments. As shown in Fig. 8a and b, bacterial cells in PBS control and PBS + laser groups maintained structural integrity with intact cell walls and membranes. Conversely, laser-activated treatment groups (POP + laser, PEB-COP-Cu + laser, and PEB-COP-Cu + H2O2 + laser) exhibited substantial cellular damage. Most notably, the PEB-COP-Cu + H2O2 + laser group demonstrated severe membrane disintegration and cytoplasmic leakage, significantly exceeding damage observed in other groups. These findings confirmed the synergistic bactericidal mechanism combining photothermal/photocatalytic properties of PEB-COP-Cu with enzymatic activities.54
Bacterial viability was quantified using SYTO9/PI dual-staining (Fig. 9). As seen, the control groups (PBS with/without laser) exhibited exclusive green fluorescence. Conversely, laser-activated treatments (PEB-COP-Cu + laser; PEB-COP-Cu + H2O2 + laser) showed dominant red fluorescence (Fig. 9c–f), with maximal intensity in the PEB-COP-Cu + H2O2 + laser group, aligning with TEM observations of severe cellular damage. Quantitative analysis revealed the PEB-COP-Cu alone induced minimal death, as verified by the weak red fluorescence (<5%), due to mimicking-OXD activity. However, the addition of external stimuli (Laser irradiation or the H2O2) triggered robust ROS generation, especially the concurrently exertion of laser and H2O2 (>90% red fluorescence). This dual staining strategy corroborated the TEM findings and demonstrated the multimodal antimicrobial efficacy of PEB-COP-Cu through combined PDT, PTT, and dual enzymatic pathways.
Building on its exceptional antimicrobial properties, the biofilm inhibition efficacy of PEB-COP-Cu was evaluated via Crystal violet (CV) assay.55 Stereomicroscopy (Fig. 10a) revealed substantial residual biofilms in PEB-COP-Cu-only groups (without activation). Significant degradation occurred upon activation (laser or H2O2), with maximal biofilm clearance observed under combined PEB-COP-Cu + H2O2 + laser treatment. Crystal violet quantification (Fig. 10b and c) confirmed the advantage of PEB-COP-Cu + H2O2 + laser treatment with synergistic inhibition efficacy of 80.54 ± 0.82% and 89.02 ± 0.21% for S. aureus and E. coli. In contrast, the PEB-COP-Cu alone exhibited limited activity (9.48 ± 1.76% against S. aureus and 7.72 ± 1.06% against E. coli). Notably, PEB-COP-Cu maintained significant inhibition activity under the laser irradiation. The PEB-COP-Cu + H2O2, achieved 69.50 ± 1.06% and 15.48 ± 5.19% biofilm inhibition for E. coli and S. aureus. These results not only corroborated our earlier antimicrobial assessments, but also elucidated the unique dual-action mechanism of PEB-COP-Cu.
To assess the translational potential of PEB-COP-Cu, the in vitro biosafety was evaluated.
Initial hemocompatibility assessment via standardized erythrocyte hemolysis assay revealed a dose-dependent increase in hemolysis rate with PEB-COP-Cu concentration (Fig. 10d, and S6a). Crucially, despite this trend, hemolysis remained exceptionally low (<5%) across the entire therapeutic concentration range (0–600 μg mL−1), reaching only 2.56 ± 0.08% at the concentration of (300 μg mL−1) and a negligible 3.57 ± 1.08% even at 600 μg mL−1.56 This demonstrates outstanding blood compatibility and minimal erythrocyte membrane disruption.57
Complementing this, in vitro cytotoxicity assessment using mouse fibroblast (3T3) cells (Fig. 10e and S6b) showed consistently high cell viability (>80%) across all concentrations (0–600 μg mL−1). Critically, viability was maintained at >80% even at 300 μg mL−1 (optimal dose) and 600 μg mL−1 (maximum dose), confirming low cytotoxicity within the biologically relevant range. These collective findings robustly establish the favorable biocompatibility profile of PEB-COP-Cu at its effective antimicrobial concentrations.
Furthermore, scratch wound healing assays were performed to evaluate the capacity of PEB-COP-Cu in modulating regenerative processes. Time-lapse imaging quantified progressive wound closure, revealing significant acceleration of cellular restitution mechanisms compared to controls (Fig. 10f–g). Both PBS control and PEB-COP-Cu groups showed progressive wound closure from 0–36 h. Significantly, PEB-COP-Cu treatment accelerated cell migration, achieving 73.54 ± 3.28% closure at 36 h versus 26.46 ± 2.68% in controls. This time-dependent enhancement demonstrates the capacity of PEB-COP-Cu to stimulate reparative processes.58 In conclusion, PEB-COP-Cu leverages the divergent pathophysiological conditions, particularly the pH gradient and ROS homeostasis, between the infected microenvironment (acidic pH, ROS amplification susceptibility, stressed antioxidants) and normal tissue (neutral pH, robust antioxidant capacity) to achieve selective bacterial eradication. Critically, the controlled, context-dependent release of essential copper ions at the wound site also contributes positively to tissue regeneration through established pro-healing biological pathways.
The in vivo assay was finely evaluated utilizing a S. aureus-infected dorsal wound model in KM rats. All animal experiments adhered strictly to the animal experimentation guidelines of Shandong Second Medical University.59 The rats were divided into six groups, including the PBS (I), PEB-COP-Cu (II), laser (III), PEB-COP-Cu + H2O2 (IV), PEB-COP-Cu + laser (V), and PEB-COP-Cu + H2O2 + laser (VI). On the initial day of treatment, all groups exhibited pus and redness due to bacterial infection, with wounds visibly stretched and deformed, confirming the successful establishment of the infected wound model. As seen from Fig. 11a, the wounds in all these therapeutic groups were gradually decreased with the duration of time, but varied degrees of healing were detected in different groups. Quantitative tracking of wound closure (Fig. 11b, and d) revealed accelerated healing in laser-activated groups, particularly the PEB-COP-Cu + H2O2 + laser group. Notably, Group VI exhibited the most pronounced wound healing enhancement, demonstrating synergistic therapeutic efficacy in infected wound repair. Specifically, by the 5th day post-infection, the wounds began to contract in the PEB-COP-Cu + H2O2 + laser as the decrease of wound area decreased to 46.62 ± 3.31% (vs. 57.42 ± 3.29% of PEB-COP-Cu + laser, 67.81 ± 5.84% of PEB-COP-Cu + H2O2, 73.87 ± 4.13% of PBS + laser, 68.11 ± 8.14% of PEB-COP-Cu, and 73.39 ± 2.31% of PBS). On day 11, the PEB-COP-Cu + H2O2 + laser (VI) group achieved a wound healing rate of 95.82 ± 0.30%, outperforming the other groups (88.72 ± 1.15%, 75.63 ± 2.69%, 69.84 ± 3.90% 3.51 ± 1.32%, and 69.40 ± 1.60% for the PEB-COP-Cu + laser, PEB-COP-Cu + H2O2, PBS + laser, PEB-COP-Cu, and PBS, respectively). These consequences showed the great efficacy of PEB-COP-Cu + H2O2 + laser in bacterial eradication and wound healing, facilitated by the synergistic action of enzyme catalysis and photo therapy. Furthermore, as presented in Fig. 11c, similar to the PBS group, the body weights of mice in various treatment groups was all increased stable during the 11 days treatment with no intensive fluctuation. Histopathological assessment via hematoxylin-eosin (H&E) and Masson trichrome staining revealed advanced tissue regeneration in Group VI, characterized by complete epidermal reconstruction, robust neovascularization and minimal inflammatory infiltrate (Fig. 11e). This regenerative profile demonstrated significant bacterial clearance coupled with accelerated wound contraction of PEB-COP-Cu. The combinatorial photo-enzymatic strategy outperformed monotherapies through synergistic tissue remodeling. The systemic biocompatibility of PEB-COP-Cu was further evaluated through comprehensive hematological and histopathological analyses. On day 11, orbital venous plexus blood samples collected from all groups (Fig. S5) revealed no statistically significant alterations in hematological parameters compared to controls, confirming systemic hemocompatibility. Furthermore, histological examination using H&E staining of all major organs of the mice revealed no significant tissue damage, indicating that PEB-COP-Cu exhibited excellent biosafety and did not elicit any notable adverse effects on the tissues and organs (Fig. 11f).60
The SI includes a comprehensive list of all chemicals, solvents, and biological materials used, along with their sources and purity levels; experimental procedures; characterization data such as 1H-NMR spectra, N2 adsorption isotherms, pore size distribution curves, and EDS spectra; optical properties including UV-visible spectra and corresponding calibration curves; assessments of light and water stability; temperature-dependent POD and OXD mimetic activities; studies on photothermal antibacterial efficacy; biocompatibility evaluations; in vivo blood test results from mouse models; supplementary tables; and a full set of supporting references. See DOI: https://doi.org/10.1039/d5ra04493f.
Footnote |
† These authors contribute equal to this work. |
This journal is © The Royal Society of Chemistry 2025 |